MABCAMPATH

Google image searchProduct monograph

Active ingredient

alemtuzumab, 30 MG/ML

DIN: 02290960

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 19-APR-2024

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AG — Monoclonal antibodies (ATC, ATC/DDD)
• L04AG06 — ALEMTUZUMAB (ATC/DDD)

Reference brand drug: Lemtrada, Mabcampath

External Links for Mabcampath

Search on Google

• Mabcampath side effects
• Mabcampath dosage
• alemtuzumab side effects
• alemtuzumab dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find mabcampath photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.